Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits
Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt.
AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?
Cardiologist-founded startup announces FDA clearance, first uses of new TAVR pacing system
“The device takes variability out of the procedure by giving the operator full control while automating ramp-up and back-up algorithms," according to a clinician who used the new technology. "The TAVR procedure is simplified, reducing physician and staff workload."

Cardiovascular research taking a hit during pandemic

As the COVID-19 pandemic continues, researchers have been forced to put important projects on hold—and it’s unclear when things will return to normal.

The saga continues: 3 White House experts say hydroxychloroquine ineffective as a COVID-19 treatment

In the last six days, multiple White House experts have all emphasized they don’t support the use of hydroxychloroquine as a treatment option for COVID-19.

Updated cardiac imaging recommendations for treating COVID-19 patients

Differentiating between actual signs of a COVID-19 infection and standard cardiac complications can be especially difficult.

CV societies ‘very concerned’ about proposed coverage changes for MR therapy

The American College of Cardiology, Society of Thoracic Surgeons, American Association for Thoracic Surgery and Society for Cardiovascular Angiography and Interventions all collaborated on the response.

Pfizer CEO: Expecting pharma to fight COVID for free ‘very fanatic and radical’

The head of the largest pharmaceutical company by revenues is pulling no punches defending the profit motive in the fight against COVID-19.

Evolocumab use benefits people living with HIV, dyslipidemia patients

Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”

Alien DNA, retractions, whistleblowers and more: The wild saga of hydroxychloroquine and COVID-19 continues

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here?

How social distancing, outdoor temperatures impact the spread of COVID-19

Researchers tracked data related to more than 178 million U.S. residents. Their findings could help with the development of public policies going forward.

Clinical

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits

AI-based coronary plaque evaluations highlight elevated heart risks in women

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

Cardiologist-founded startup announces FDA clearance, first uses of new TAVR pacing system